Gynecological Cancer

EDU 43 - How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers

Moderator(s)

• 

  Mitchell Kamrava, MD, MS

  Cedars Sinai Medical Center
  LA, CA

Sentinel lymph node biopsies are being rapidly adopted in endometrial, vulvar and cervical cancers. While this is exciting, its also created confusion regarding indications of adjuvant radiation which have, to date, been based on lymphadenectomy data. Sentinel lymph node data has opened considerations of what to do with macrometastasis, micrometastasis and isolated tumor cells. How best to integrate this new information with traditional risk factors is evolving and varies for endometrial, cervical and vulvar cancers. These new issues are also not addressed in the recent ASTRO clinical guidelines in endometrial and cervical cancers. This session proposes to provide up to date clinical guidance on the integration and impact on radiation treatment in endometrial, cervical and vulvar cancers.

Presentations:

• 12:45 PM – 12:47 PM ET

  Introductions
  

  Speaker: Mitchell Kamrava, MD, MS – Cedars Sinai Medical Center
• 12:47 PM – 1:07 PM ET

  Integrating SLNBx Data in Vulvar Cancer
  

  Speaker: Sushil Beriwal, MD, MBA, FASTRO – Allegheny Health Network
• 1:07 PM – 1:27 PM ET

  Integrating SLNBx Data in Endometrial Cancer
  

  Speaker: Christine Fisher, MD, MPH – University of Colorado Denver
• 1:27 PM – 1:47 PM ET

  Integrating SLNBx Data in Cervical Cancer
  

  Speaker: Jyoti Mayadev, MD, FASTRO – UCSD
• 1:47 PM – 2:00 PM ET

  Questions and Answers
  

  Speaker: Mitchell Kamrava, MD, MS – Cedars Sinai Medical Center